skip to main content

Lipid therapy liver tests — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsLipid therapy liver testsGPhC CRA

A patient started atorvastatin three months ago asks whether blood tests are still needed. They feel well and have no muscle symptoms. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Check liver function after starting or changing dose

Liver function should be checked after initiation or dose change according to local and BNF guidance. Absence of symptoms does not remove the need for early monitoring. In this scenario, the correct option is check liver function after starting or changing dose. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF